Area surrounding a tumor impacts how breast cancer cells grow

by Amanda Gibbs,Oregon Health & Science University“Cancer is acomplex mixture of cancer cells, normal blood cells, tissue and immune cells. Tumor cells themselves alter the microenviro

Updated on: April 07,2024

Area surrounding a tumor impacts how breast cancer cells grow

by Amanda Gibbs,Oregon Health & Science University“Cancer is acomplex mixture of cancer cells, normal blood cells, tissue and immune cells. Tumor cells themselves alter the microenviro

Updated on:April 07,2024

Testosterone therapy may protect against breast cancer in trans masculine individuals

by Jacqueline Mitchell,Beth Israel Deaconess Medical Centera) Lobular atrophy was assessed by the pathologists using four categories. b) The duration of testosterone therapy (TT) significantly c

Updated on: August 03,2024

Testosterone therapy may protect against breast cancer in trans masculine individuals

by Jacqueline Mitchell,Beth Israel Deaconess Medical Centera) Lobular atrophy was assessed by the pathologists using four categories. b) The duration of testosterone therapy (TT) significantly c

Updated on:August 03,2024

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by University of HelsinkiSchematics showing the overview of data sets, analysis, and validation and extensions. Picture created with biorender.com. Credit:Leukemia(2023). DOI: 10.1038

Updated on: April 18,2024

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by University of HelsinkiSchematics showing the overview of data sets, analysis, and validation and extensions. Picture created with biorender.com. Credit:Leukemia(2023). DOI: 10.1038

Updated on:April 18,2024

Incidence of cutaneous T-cell lymphoma up in the U.S.

The overall incidence of cutaneous T-cell lymphoma (CTCL) increased in the United States from 2000 to 2018, according to a research letter published online Sept. 1 inJAMA Oncology.Zhuo Ran Cai,

Updated on: January 02,2024

Incidence of cutaneous T-cell lymphoma up in the U.S.

The overall incidence of cutaneous T-cell lymphoma (CTCL) increased in the United States from 2000 to 2018, according to a research letter published online Sept. 1 inJAMA Oncology.Zhuo Ran Cai,

Updated on:January 02,2024

Study hints at new target to improve immune therapy in triple-negative breast cancer

by CU Anschutz Medical CampusHeide Ford, PhD, and University of Colorado Cancer Center colleagues show that Eya3 may regulate immune response to triple-negative breast cancer, potentially improvi

Updated on: June 01,2024

Study hints at new target to improve immune therapy in triple-negative breast cancer

by CU Anschutz Medical CampusHeide Ford, PhD, and University of Colorado Cancer Center colleagues show that Eya3 may regulate immune response to triple-negative breast cancer, potentially improvi

Updated on:June 01,2024

New treatment for urinary tract cancer could prevent kidney dialysis, transplant

by Michelle Brubaker,University of California - San DiegoCredit: Pixabay/CC0 Public DomainUC San Diego Health is now offering a new treatment for patients with low-grade upper tract urothelial c

Updated on: January 02,2024

New treatment for urinary tract cancer could prevent kidney dialysis, transplant

by Michelle Brubaker,University of California - San DiegoCredit: Pixabay/CC0 Public DomainUC San Diego Health is now offering a new treatment for patients with low-grade upper tract urothelial c

Updated on:January 02,2024

Team discovers gene mutations linked to pancreatic cancer

by Susan Buckles,Mayo ClinicCredit: Mayo ClinicSix genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's acc

Updated on: May 27,2024

Team discovers gene mutations linked to pancreatic cancer

by Susan Buckles,Mayo ClinicCredit: Mayo ClinicSix genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's acc

Updated on:May 27,2024

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

by Molly Chiu,Baylor College of MedicineKaplan-Meier Survival Outcomes of Cancer-Predisposition Variant (CPV) Status on Rhabdomyosarcoma (RMS). Credit:JAMA Network Open(2024). DOI: 1

Updated on: March 30,2024

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

by Molly Chiu,Baylor College of MedicineKaplan-Meier Survival Outcomes of Cancer-Predisposition Variant (CPV) Status on Rhabdomyosarcoma (RMS). Credit:JAMA Network Open(2024). DOI: 1

Updated on:March 30,2024

A new way to predict complications after larynx cancer surgery

by Nicole Fawcett,University of MichiganRebecca Hoesli, M.D., and Matthew Spector, M.D., evaluate an image from the study Credit: University of Michigan Rogel Cancer CenterA technique that illum

Updated on: May 17,2024

A new way to predict complications after larynx cancer surgery

by Nicole Fawcett,University of MichiganRebecca Hoesli, M.D., and Matthew Spector, M.D., evaluate an image from the study Credit: University of Michigan Rogel Cancer CenterA technique that illum

Updated on:May 17,2024

Survey finds one in three patients needed more information on cancer treatment side effects

by American Society for Radiation OncologyIn a nationwide survey of US adults treated for cancer, 1 in 3 patients said they experienced side effects from cancer treatment that they wish they'

Updated on: March 06,2024

Survey finds one in three patients needed more information on cancer treatment side effects

by American Society for Radiation OncologyIn a nationwide survey of US adults treated for cancer, 1 in 3 patients said they experienced side effects from cancer treatment that they wish they'

Updated on:March 06,2024

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Updated on: September 27,2024

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Updated on:September 27,2024

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and

Updated on: January 04,2024

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and

Updated on:January 04,2024